J Pediatr Intensive Care 2018; 07(02): 097-101
DOI: 10.1055/s-0037-1607325
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Community-Acquired MRSA Pericarditis and Mediastinitis in a Previously Healthy Infant

Joselito Sanchez
1   Division of Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York
,
Amanda Schneider
2   Department of Pediatrics, New York University School of Medicine, New York, New York
,
Justin T. Tretter
3   Division of Cardiology, Department of Pediatrics, New York University School of Medicine, New York, New York
,
Bo Shopsin
4   Division of Infectious Diseases, Department of Medicine, New York University School of Medicine, New York, New York
,
Yasir Al-Qaqaa
5   Division of Critical Care, Department of Pediatrics, New York University School of Medicine, New York, New York
,
Alka Khaitan
1   Division of Infectious Diseases and Immunology, Department of Pediatrics, New York University School of Medicine, New York, New York
,
Tanya Chadha
6   Division of Critical Care, Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida
› Author Affiliations
Funding Genotyping of the MRSA isolates was supported by the National Institutes of Health (R01-AI103268 to Bo Shopsin).
Further Information

Publication History

06 July 2017

16 September 2017

Publication Date:
26 October 2017 (online)

Abstract

Invasive community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections disproportionately affect children, but there are few pediatric reports of pericarditis and mediastinitis caused by CA-MRSA in previously healthy children. Here we report a severe case of CA-MRSA pericarditis with extension to the mediastinum and carotid sheath in a previously healthy 8-month-old infant who was successfully treated with surgical interventions and with a combination of daptomycin and vancomycin. The relatively indolent clinical course in this patient was notable given the significant extent of infection. This case highlights the potential virulence of CA-MRSA in previously healthy children and the importance of early diagnosis, prompt drainage, and appropriate antibiotic coverage.

 
  • References

  • 1 Lutmer JE, Yates AR, Bannerman TL, Marcon MJ, Karsies TJ. Purulent pericarditis secondary to community-acquired, methicillin-resistant Staphylococcus aureus in previously healthy children. A sign of the times?. Ann Am Thorac Soc 2013; 10 (03) 235-238
  • 2 Wang CM, Chuang CH, Chiu CH. Community-acquired disseminated methicillin-resistant Staphylococcus aureus infection: case report and clinical implications. Ann Trop Paediatr 2005; 25 (01) 53-57
  • 3 Mera RM, Suaya JA, Amrine-Madsen H. , et al. Increasing role of Staphylococcus aureus and community-acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb Drug Resist 2011; 17 (02) 321-328
  • 4 Iwamoto M, Mu Y, Lynfield R. , et al. Trends in invasive methicillin-resistant Staphylococcus aureus infections. Pediatrics 2013; 132 (04) e817-e824
  • 5 Fridkin SK, Hageman JC, Morrison M. , et al; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352 (14) 1436-1444
  • 6 Gerber JS, Coffin SE, Smathers SA, Zaoutis TE. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis 2009; 49 (01) 65-71
  • 7 Liu C, Bayer A, Cosgrove SE. , et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52 (03) 285-292
  • 8 Comeau JL, Lin TJ, Macken MB. , et al. Staphylococcal pericarditis, and liver and paratracheal abscesses as presentations in two new cases of interleukin-1 receptor associated kinase 4 deficiency. Pediatr Infect Dis J 2008; 27 (02) 170-174
  • 9 Shopsin B, Gomez M, Montgomery SO. , et al. Evaluation of protein A gene polymorphic region DNA sequencing for typing of Staphylococcus aureus strains. J Clin Microbiol 1999; 37 (11) 3556-3563
  • 10 Oliveira DC, Milheiriço C, Vinga S, de Lencastre H. Assessment of allelic variation in the ccrAB locus in methicillin-resistant Staphylococcus aureus clones. J Antimicrob Chemother 2006; 58 (01) 23-30
  • 11 Lina G, Piémont Y, Godail-Gamot F. , et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29 (05) 1128-1132
  • 12 Diep BA, Gill SR, Chang RF. , et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus . Lancet 2006; 367 (9512): 731-739
  • 13 Yoon JK, Rahimi MB, Fiore A, Schowengerdt K, Jureidini SB. Bacterial pancarditis with myocardial abscess: successful surgical intervention in a 14-month-old boy. Tex Heart Inst J 2015; 42 (01) 55-57
  • 14 Natrajsetty HS, Vijayalakshmi IB, Narasimhan C, Manjunath CN. Purulent pericarditis with quadruple valve endocarditis. Am J Case Rep 2015; 16: 236-239
  • 15 Kumar S, Sharma N, Singh R, Bhalla A, Varma S. Pyopericardium complicated with cardiac tamponade: an unusual presenting manifestation of primary pyomyositis. Trop Doct 2013; 43 (01) 39-40
  • 16 Miyamoto T, Tomoyasu T, Miyaji K. Successful treatment of pediatric endocarditis and pericarditis due to MRSA with linezolid. Jpn J Antibiot 2011; 64 (02) 109-112
  • 17 Hoehn KS, Capouya JD, Daum RS. , et al. Lemierre-like syndrome caused by community-associated methicillin-resistant Staphylococcus aureus complicated by hemorrhagic pericarditis. Pediatr Crit Care Med 2010; 11 (03) e32-e35
  • 18 Luther MK, LaPlante KL. Observed antagonistic effect of linezolid on daptomycin or vancomycin activity against biofilm-forming methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 2015; 59 (12) 7790-7794
  • 19 Cohen-Wolkowiez M, Watt KM, Hornik CP, Benjamin Jr DK, Smith PB. Pharmacokinetics and tolerability of single-dose daptomycin in young infants. Pediatr Infect Dis J 2012; 31 (09) 935-937
  • 20 Prabhudesai S, Kanjani A, Nambi PS, Gnanasambandam S, Ramachandran B. Successful use of high-dose daptomycin in a child with Staphylococcus aureus endocarditis. Pediatr Infect Dis J 2016; 35 (05) 517-518
  • 21 Syriopoulou V, Dailiana Z, Dmitriy N, Utili R, Pathan R, Hamed K. Clinical experience with daptomycin for the treatment of gram-positive infections in children and adolescents. Pediatr Infect Dis J 2016; 35 (05) 511-516
  • 22 Garazzino S, Castagnola E, Di Gangi M. , et al; SITIP Daptomycin Study Group. Daptomycin for children in clinical practice experience. Pediatr Infect Dis J 2016; 35 (06) 639-641
  • 23 Ardura MI, Mejías A, Katz KS, Revell P, McCracken Jr GH, Sánchez PJ. Daptomycin therapy for invasive Gram-positive bacterial infections in children. Pediatr Infect Dis J 2007; 26 (12) 1128-1132
  • 24 Palma DM, Giordano S, Neville Cracchiolo A, Zangara V, Coffaro G, Tetamo R. Daptomycin in the treatment of invasive gram-positive bacterial infections in children: personal experience. Minerva Pediatr 2013; 65 (02) 173-178
  • 25 Bradley J, Glasser C, Patino H. , et al. Daptomycin for complicated skin infections: a randomized trial. Pediatrics 2017; 139 (03) e20162477
  • 26 Abdel-Rahman SM, Chandorkar G, Akins RL. , et al. Single-dose pharmacokinetics and tolerability of daptomycin 8 to 10 mg/kg in children aged 2 to 6 years with suspected or proved gram-positive infections. Pediatr Infect Dis J 2011; 30 (08) 712-714
  • 27 Abdel-Rahman SM, Benziger DP, Jacobs RF, Jafri HS, Hong EF, Kearns GL. Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections. Pediatr Infect Dis J 2008; 27 (04) 330-334
  • 28 Tedeschi S, Tumietto F, Conti M, Giannella M, Viale P. ; S. Orsola Antimicrobial Stewardship Team. Use of daptomycin in critically ill children with bloodstream infections and complicated skin and soft-tissue infections. Pediatr Infect Dis J 2016; 35 (02) 180-182
  • 29 Phillips J, Cardile AP, Patterson TF, Lewis II JS. Daptomycin-induced acute eosinophilic pneumonia: analysis of the current data and illustrative case reports. Scand J Infect Dis 2013; 45 (10) 804-808